Cargando…

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry

BACKGROUND: Current statin use and symptoms among older adults in routine community practice have not been well characterized since the release of the 2013 American College of Cardiology/American Heart Association guideline. METHODS AND RESULTS: We compared statin use and dosing between adults >7...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nanna, Michael G., Navar, Ann Marie, Wang, Tracy Y., Mi, Xiaojuan, Virani, Salim S., Louie, Michael J., Lee, L. Veronica, Goldberg, Anne C., Roger, Veronique L., Robinson, Jennifer, Peterson, Eric D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015311/ https://www.ncbi.nlm.nih.gov/pubmed/29739801 http://dx.doi.org/10.1161/JAHA.118.008546

Ejemplares similares

Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry
por: Bradley, Corey K., et al.
Publicado: (2019)

Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry
por: Xian, Ying, et al.
Publicado: (2019)

Patient perceptions and use of non‐statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry
por: Lowenstern, Angela, et al.
Publicado: (2021)

Measurement of Low‐Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry
por: Lowenstern, Angela M., et al.
Publicado: (2018)

Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin‐Associated Side Effects
por: Ahmed, Sarah T., et al.
Publicado: (2020)

Association of Primary Care Providers’ Beliefs of Statins for Primary Prevention and Statin Prescription
por: Clough, Jeffrey D., et al.
Publicado: (2019)

CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins?
por: Jia, Xiaoming, et al.
Publicado: (2019)

Statins in COVID-19 infection: A rehash of old themes or truly a new hope?
por: Jia, Xiaoming, et al.
Publicado: (2021)

Lipid Testing and Statin Dosing After Acute Myocardial Infarction
por: Wang, William T., et al.
Publicado: (2018)

Phenotyping Adverse Drug Reactions: Statin-Related Myotoxicity
por: Wiley, Laura K., et al.
Publicado: (2015)

A Tumor-Like Lump in the Palm Caused by an Inconspicuous-for 75 Years-Bullet
por: Athanaselis, Efstratios D., et al.
Publicado: (2020)

Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi‐Ethnic Study of Atherosclerosis)
por: Miedema, Michael D., et al.
Publicado: (2018)

Statins Neuromuscular Adverse Effects
por: Attardo, Silvia, et al.
Publicado: (2022)

Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry
por: Basra, Sukhdeep S., et al.
Publicado: (2018)

Efficacy of alirocumab according to background statin type and dose: pooled analysis of 8 ODYSSEY Phase 3 clinical trials
por: Catapano, Alberico L., et al.
Publicado: (2017)

Secondary prevention of cardiovascular diseases in India: Findings from registries and large cohorts
por: Rehman, Hasan, et al.
Publicado: (2020)

A Propensity Score Matched Analysis of Statin Effects on Major Adverse Cardiac Events after Percutaneous Coronary Intervention in Patients Over 75 Years Old
por: Horikoshi, Takeo, et al.
Publicado: (2022)

Early efficacy and safety of statin therapy in Korean patients with hypercholesterolemia: Daegu and Gyeongbuk Statin Registry
por: Bae, Han Joon, et al.
Publicado: (2020)

Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation
por: Chen, Nemin, et al.
Publicado: (2020)

Pharmacogenomics of statins: understanding susceptibility to adverse effects
por: Kitzmiller, Joseph P, et al.
Publicado: (2016)

Provider‐Level Variation in Smoking Cessation Assistance Provided in the Cardiology Clinics: Insights From the NCDR PINNACLE Registry
por: Sardana, Mayank, et al.
Publicado: (2019)

Prevalence, treatment, and control of severe hyperlipidemia
por: Gold, Matthew E., et al.
Publicado: (2020)

Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease
por: Gobbel, Glenn T., et al.
Publicado: (2021)

Statin-induced necrotizing autoimmune myopathy: an extremely rare adverse effect from statin use
por: Sharma, Priyadarshani, et al.
Publicado: (2019)

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins
por: Arrigoni, Elena, et al.
Publicado: (2017)

Chronic Stress and Risks for Myocardial Infarction in U.S. Adults
por: Farmer, Heather, et al.
Publicado: (2020)

Assessing the effectiveness of statin therapy for alleviating cerebral small vessel disease progression in people ≥75 years of age
por: Guo, Yuqi, et al.
Publicado: (2020)

Palm readings.
por: Frazer, L
Publicado: (1998)

Statin-Associated Necrotizing Autoimmune Myositis Complicated by an Uncommon Adverse Effect to Treatment
por: Fung, Brian M., et al.
Publicado: (2019)

Pharmacogenomics of response to statin treatment and susceptibility to statin-induced adverse drug reactions in Asians: a scoping review
por: Yow, Hui-Yin, et al.
Publicado: (2023)

Assessing Muscle-Related Adverse Events in Randomized Trials of Statins
por: Doshi, Peter, et al.
Publicado: (2022)

Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France
por: Giral, Philippe, et al.
Publicado: (2019)

Do cholesterol levels and continuity of statin use affect colorectal cancer incidence in older adults under 75 years of age?
por: Han, Kyu-Tae, et al.
Publicado: (2021)

Childhood Adversity as a Predictor of Non-Adherence to Statin Therapy in Adulthood
por: Korhonen, Maarit Jaana, et al.
Publicado: (2015)

The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins
por: Mo, Huanbiao, et al.
Publicado: (2019)

Statin associated adverse reactions in Latin America: a scoping review
por: Urina-Jassir, Manuel, et al.
Publicado: (2021)

TCT CONNECT-223 Effects of the COVID-19 Pandemic on a Population Older Than 75 Years With Previous Percutaneous Coronary Revascularization: Subanalysis of the SIERRA 75 Registry
por: De la Torre Hernandez, Jose, et al.
Publicado: (2020)

PalmXplore: oil palm gene database
por: Sanusi, Nik Shazana Nik Mohd, et al.
Publicado: (2018)

Statin Induced Autoimmune Necrotizing Myopathy (SIANM): An Alarming Adverse Event of a Familiar Medication
por: Ganta, Nagapratap, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o7u4e106f7rtg46ft2bjjrarjo